Annual SG&A
$27.11 M
-$1.28 M-4.51%
31 December 2023
Summary:
Black Diamond Therapeutics annual selling, general & administrative expenses is currently $27.11 million, with the most recent change of -$1.28 million (-4.51%) on 31 December 2023. During the last 3 years, it has risen by +$5.75 million (+26.91%). BDTX annual SG&A is now -9.76% below its all-time high of $30.04 million, reached on 31 December 2021.BDTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.22 M
-$4.36 M-45.52%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly selling, general & administrative expenses is currently $5.22 million, with the most recent change of -$4.36 million (-45.52%) on 30 September 2024. Over the past year, it has dropped by -$2.64 million (-33.62%). BDTX quarterly SG&A is now -45.52% below its all-time high of $9.57 million, reached on 30 June 2024.BDTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.78 B
-$73.10 M-4.28%
30 September 2024
Summary:
Black Diamond Therapeutics TTM selling, general & administrative expenses is currently -$1.78 billion, with the most recent change of -$73.10 million (-4.28%) on 30 September 2024. Over the past year, it has dropped by -$1.81 billion (-6282.56%). BDTX TTM SG&A is now -11227.48% below its all-time high of $30.04 million, reached on 31 December 2021.BDTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.5% | -33.6% | -6282.6% |
| 3 y3 years | +26.9% | -32.6% | -6225.8% |
| 5 y5 years | +1287.4% | +107.5% | -10000.0% |
BDTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -9.8% | +26.9% | -45.5% | at low | -166.6% | at low |
| 5 y | 5 years | -9.8% | +1287.4% | -45.5% | +107.5% | -3033.0% | at low |
| alltime | all time | -9.8% | +3970.6% | -45.5% | +682.0% | <-9999.0% | at low |
Black Diamond Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.22 M(-45.5%) | $27.06 M(-8.9%) |
| June 2024 | - | $9.57 M(+42.9%) | $29.70 M(+10.0%) |
| Mar 2024 | - | $6.70 M(+20.4%) | $27.00 M(-0.4%) |
| Dec 2023 | $27.11 M(-4.5%) | $5.57 M(-29.2%) | $27.11 M(-5.8%) |
| Sept 2023 | - | $7.86 M(+14.2%) | $28.79 M(+5.8%) |
| June 2023 | - | $6.88 M(+1.0%) | $27.21 M(-0.4%) |
| Mar 2023 | - | $6.81 M(-6.0%) | $27.31 M(-3.8%) |
| Dec 2022 | $28.39 M(-5.5%) | $7.24 M(+15.4%) | $28.39 M(+3.0%) |
| Sept 2022 | - | $6.28 M(-10.0%) | $27.56 M(-5.0%) |
| June 2022 | - | $6.98 M(-11.6%) | $29.02 M(-3.4%) |
| Mar 2022 | - | $7.89 M(+23.0%) | $30.04 M(0.0%) |
| Dec 2021 | $30.04 M | $6.42 M(-17.1%) | $30.04 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $7.74 M(-3.2%) | $29.05 M(+8.1%) |
| June 2021 | - | $8.00 M(+1.3%) | $26.87 M(+13.2%) |
| Mar 2021 | - | $7.89 M(+45.4%) | $23.73 M(+11.1%) |
| Dec 2020 | $21.36 M(+181.8%) | $5.43 M(-2.2%) | $21.36 M(+13.5%) |
| Sept 2020 | - | $5.55 M(+14.3%) | $18.82 M(+19.2%) |
| June 2020 | - | $4.86 M(-12.1%) | $15.78 M(+28.6%) |
| Mar 2020 | - | $5.53 M(+91.6%) | $12.28 M(+62.0%) |
| Dec 2019 | $7.58 M(+287.9%) | $2.88 M(+14.7%) | $7.58 M(+41.3%) |
| Sept 2019 | - | $2.51 M(+85.8%) | $5.36 M(+88.3%) |
| June 2019 | - | $1.35 M(+63.4%) | $2.85 M(+90.5%) |
| Mar 2019 | - | $828.00 K(+24.1%) | $1.50 M(+124.1%) |
| Dec 2018 | $1.95 M(+193.4%) | $667.00 K | $667.00 K |
| Dec 2017 | $666.00 K | - | - |
FAQ
- What is Black Diamond Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual SG&A year-on-year change?
- What is Black Diamond Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly SG&A year-on-year change?
- What is Black Diamond Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM SG&A year-on-year change?
What is Black Diamond Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of BDTX is $27.11 M
What is the all time high annual SG&A for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual selling, general & administrative expenses is $30.04 M
What is Black Diamond Therapeutics annual SG&A year-on-year change?
Over the past year, BDTX annual selling, general & administrative expenses has changed by -$1.28 M (-4.51%)
What is Black Diamond Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of BDTX is $5.22 M
What is the all time high quarterly SG&A for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly selling, general & administrative expenses is $9.57 M
What is Black Diamond Therapeutics quarterly SG&A year-on-year change?
Over the past year, BDTX quarterly selling, general & administrative expenses has changed by -$2.64 M (-33.62%)
What is Black Diamond Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of BDTX is -$1.78 B
What is the all time high TTM SG&A for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM selling, general & administrative expenses is $30.04 M
What is Black Diamond Therapeutics TTM SG&A year-on-year change?
Over the past year, BDTX TTM selling, general & administrative expenses has changed by -$1.81 B (-6282.56%)